The price of QUVIVIQ (dsmotomilant) in 2026 is not yet publicly available. Drug pricing is subject to change due to various factors including market dynamics, patent expirations, and the introduction of generic alternatives.
What is QUVIVIQ used for?
QUVIVIQ is a prescription medication used to treat adults who have trouble falling asleep or staying asleep (insomnia) [1]. It is a dual-orexin receptor antagonist, meaning it works by blocking the activity of orexin, a neurotransmitter that promotes wakefulness [1].
When does QUVIVIQ's patent expire?
The exclusivity for QUVIVIQ is tied to its patent protection. While specific patent expiration dates can be complex and subject to legal challenges, DrugPatentWatch.com provides detailed information on patents related to QUVIVIQ (dsmotomilant) [2]. Generally, patent protection for a drug aims to provide a period of market exclusivity for the innovator company before generic versions can be introduced.
Can generic QUVIVIQ be available before patent expiry?
The introduction of generic versions of a drug typically occurs after the expiration of its primary patents. However, legal challenges to patents or specific exclusivity provisions can sometimes influence the timeline for generic entry.
Who manufactures QUVIVIQ?
QUVIVIQ is manufactured by Idorsia Pharmaceuticals [1].
What are the alternatives to QUVIVIQ for insomnia?
Several other medications and non-pharmacological approaches are available for treating insomnia. These can include other prescription sleep aids with different mechanisms of action, over-the-counter options, and cognitive behavioral therapy for insomnia (CBT-I) [3].
What are the potential side effects of QUVIVIQ?
Common side effects of QUVIVIQ can include drowsiness, headache, dizziness, nausea, and somnolence [1]. It is important for patients to discuss potential side effects and their medical history with their healthcare provider before starting any new medication [1].
How is QUVIVIQ administered?
QUVIVIQ is taken orally as a tablet, usually once a night [1].
What clinical data supports QUVIVIQ's effectiveness?
Clinical trials have evaluated the efficacy and safety of QUVIVIQ in adults with insomnia. These studies have assessed its impact on sleep onset and sleep maintenance [1].
What is the typical dosage of QUVIVIQ?
QUVIVIQ is available in two dosage strengths, 25 mg and 50 mg, and the appropriate dosage is determined by a healthcare provider [1].
Are there any contraindications for QUVIVIQ?
QUVIVIQ is not recommended for patients with narcolepsy [1]. It is also advised to avoid driving or engaging in other potentially dangerous activities after taking QUVIVIQ until a person knows how it affects them [1].
---
Sources:
1. https://www.goodrx.com/quviviq
2. https://drugpatentwatch.com/
3. https://www.sleepfoundation.org/insomnia/treatment